Micro-CT analysis of LPS-induced Alveolar Bone Loss in Diabetic Mice

  • Park, Hae-Ryoung (Department of Oral Biochemistry, School of Dentistry, Chonnam National University) ;
  • Park, Byung-Ju (Department of Oral Biochemistry, School of Dentistry, Chonnam National University)
  • Received : 2012.06.21
  • Accepted : 2012.07.24
  • Published : 2012.09.30

Abstract

Periodontal disease induces an increased incidence of tooth loss, particularly in cases with an associated loss of alveolar bone and periodontal ligaments. In this study, alveolar bone loss was detected by micro-computed tomography (CT) following exposure to E. coli lipopolysaccharide (LPS) in a streptozotocin (STZ)-induced diabetic mouse model. A 10 mg/ml dosage of E. coli LPS was applied between the first, second and third molars of the mice three times a week for 10 weeks. The loss of periodontal ligaments and alveolar processes was then evaluated by micro-CT using two and three dimensional microstructure morphometric parameters. In the diabetic mice, E. coli LPS induced the destruction of periodontal ligaments and loss of alveolar process spaces. The distances between periodontal ligaments were significantly widened in the STZ-LPS group compared with the untreated STZ group. The 10 mg/ml exposure to E. coli LPS in the STZ mice also resulted in a significant decrease in the alveolar bone volume fraction. The results of our study suggest that alveolar bone loss can be readily detected by volumetric micro-CT analysis as an increase in the distance between periodontal ligaments and in the alveolar process length.

Keywords

References

  1. Savage A, Eaton KA, Moles DR, Needleman I. A systematic review of definitions of periodontitis and methods that have been used to identify this disease. J Clin Periodontol. 2009;36:458-467.
  2. Southerland JH, Taylor GW, DrPH and Offenbacher S. Diabetes and Periodontal Infection: Making the Connection. Clinical Diabetes. 2005;23(4):171-178.
  3. Richard JP. The enhancement of enzymatic rate accelerations by Bronsted acid-base catalysis. Biochemistry. 1998;37(13):4305-4309.
  4. Lee YH, Kwak DH, Kang MS, Bhattarai G, Lee NH, Jhee EC, Yi HK. PPAR$\gamma$ Inhibits Inflammation through the Suppression of ERK1/2 Kinase Activity in Human Gingival Fibroblasts. Int J Oral Biol. 2010;35(1):27-33.
  5. Kawai T, Matsuyama T, Hosokawa Y, Makihira S, Seki M, Karimbux NY, Taubman MA. B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease. Am J Pathol. 2006;169(3):987-998.
  6. Nair SP, Meghji S, Wilson M, Reddi K, White P, & Henderson B. Bacterially induced bone destruction: mechanisms and misconceptions. Infect Immun. 1996;64(7):2371-2380.
  7. Kim SR, Jeong SK, Kim WS, Jeon HJ, ParkHJ, Kim MK, Jang HO, Yun I, Bae SK, Bae MK. The Lipopolysaccharide from Porphyromonas gingivalis Induces Vascular Permeability. Int J Oral Biol. 2011;36(1):23-29.
  8. Lu H, Raptis M, Black E, Stan M, Amar S, Graves DT. Influence of diabetes on the exacerbation of an inflammatory response in cardiovascular tissue. Endocrinology. 2004;145(11): 4934-4939.
  9. Meghji S, Qureshi W, Henderson B, Harris M. The role of endotoxin and cytokines in the pathogenesis of odontogenic cysts. Arch Oral Biol.1996; 41:523-531.
  10. Takata T, Miyauchi M, Ogawa I, Ito H, Kobayashi J, Nikai H. Reactive change in proliferative activity of the junctional epithelium after topical application of lipopolysaccharide. J Periodontol .1997;68:531-8535.
  11. Park CH, Abramson ZR, Taba MJ, Jin Q, Chang J, Kreider JM, Goldstein SA, Giannobile WV. Three-dimensional micro-computed tomographic imaging of alveolar bone in experimental bone loss or repair. J Periodontol. 2007;78(2): 273-281.
  12. Catalano MA, Carson DA, Slovin SF, Richman DD, Vaughan JH. Antibodies toEpstein-Barr virus-determined antigens in normal subjects and in patients with seropositive rheumatoid arthritis. Proc Natl Acad Sci U S A. 1979;76(11): 5825-5828.
  13. Sartori R, Li F, Kirkwood KL. MAP kinase phosphatase-1 protects against inflammatory bone loss. J Dent Res. 2009;88:1125-1130.
  14. Baker PJ. The role of immune responses in bone loss during periodontal disease. Microbes Infect. 2000;2(10):1181-1192.
  15. Shimizu H, Nakagami H, Morita S, Tsukamoto I, Osako MK, Nakagami F, Morishita R. New treatment of periodontal diseases by using NF-kappaB decoy oligodeoxynucleotides via prevention of bone resorption and promotion of wound healing. Antioxid Redox Signal. 2009; 11(9): 2065-2075.
  16. Salvi GE, Collins JG, Yalda B, Arnold RR, Lang NP, OffenbacherS. Monocytic TNF alpha secretion patterns in IDDM patients with periodontal diseases. J Clin Periodontol. 1997;24(1):8-16.
  17. Salvi GE, Yalda B, Collins JG, Jones BH, Smith FW, Arnold RR, OffenbacherS. Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients. J Periodontol. 1997;68(2):127-135.
  18. Dumitrescu AL, Abd-El-Aleem S, Morales-Aza B, DonaldsonLF. A model of periodontitis in the rat: effect of lipopolysaccharide on bone resorption, osteoclast activity, and local peptidergic innervation. J Clin Periodontol. 2004;31(8):596-603.
  19. Gittens SA, Wohl GR, Zernicke RF, Matyas JR, Morley P, Uludag H. Systemic bone formation with weekly PTH administration in ovariectomized rats. J Pharm Pharm Sci. 2004;7(1):27-37.
  20. Ishijima MTK, Rittling SR, Yamashita T, Kurosawa H, Denhardt DT, Nifuji A, Noda M. Resistance to unloading- induced three-dimensional bone loss in osteopontin- deficient mice. J Bone Miner Res. 2002;17: 661-667.
  21. Montero A, Okada Y, Tomita M, Ito M, Tsurukami H, Nakamura T, HurleyMM. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J Clin Invest. 2000;105(8):1085-1093.
  22. Peterkofsky A, Wang G, Garrett DS, Lee BR, Seok YJ, Clore GM. Three-dimensional structures of protein-protein complexes in the E. coli PTS. J Mol Microbiol Biotechnol. 2001;3(3):347-354.
  23. Nason R, Lee DH, Jung JY, Chole RA. Radiographic and micro-computed tomographic imaging of lipopolysaccharide-mediated bone resorption. Ann Otol Rhinol Laryngol. 2009;118(5):391-6.